Intraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases

  • Timothy Billiar

Press/Media

Period24 Oct 2022

Media coverage

1

Media coverage

  • TitleIntraperitoneal injection of class A TLR9 agonist enhances anti–PD-1 immunotherapy in colorectal peritoneal metastases
    Media name/outletJCI Insight
    Country/TerritoryUnited States
    Date24/10/22
    URLhttps://insight.jci.org/articles/view/160063
    PersonsTimothy Billiar